Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance

Human metastatic breast cancer in the lymph nodes. National Cancer Institute – Visuals Online
Human metastatic breast cancer in the lymph nodes. National Cancer Institute – Visuals Online

Abstract:
Research from the University of Michigan Rogel Cancer Center could provide a new approach to treating an aggressive form of breast cancer.

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance

Ann Arbor, MI | Posted on May 13th, 2022

A study led by Duxin Sun, Ph.D., found that targeting the immune microenvironment in lymph nodes and tumors simultaneously led to long-term tumor remission in mice models of metastatic triple negative breast cancer. Further, using nanoparticles to deliver these immune-altering drugs increases treatment efficacy. These results appear in Science Translational Medicine.

Immunotherapy combined with chemotherapy has been long approved as standard treatment option for triple negative breast cancer but only shows a limited response in patients. Many believe that the tumor immunosuppressive microenvironment is one of the main contributing factors for the poor responses in those with TNBC.

Sun, Charles R. Walgreen Jr. Professor of Pharmacy and Professor of Pharmaceutical Sciences at the U-M College of Pharmacy, says that previously developed immunomodulators work well in animal models, but fail in clinical trials. He and his team wanted to come up with a better approach that would treat TNBC patients long-term that could withstand the rigor of clinical trials. To do this, they had to look beyond just the tumor microenvironment to the lymph nodes.

“People don’t pay enough attention to the lymph node microenvironment,” Sun said. “But it’s equally important. The lymph nodes play a crucial role in initiating the progression and metastasis of cancer.”

Sun and his team, with co-senior author Wei Gao, Ph.D., investigated strategies to modulate both the tumor and lymph node microenvironments to improve treatment response. Based on 15 years of experience, Sun knew that one type of nanomedicine could be used to deliver immune modulators to these microenvironments to alter their macrophages—a type of white blood cell of the immune system that combats pathogens, like cancer cells.

Sun’s team treated breast cancer mice models with an albumin nanoparticle, a type of nanomedicine, called Nano-PI, in combination with immunotherapies, to remodel the microenvironment in both lymph nodes and tumors. Nano-PI not only enhanced the delivery of both immunomodulators to lymph nodes and tumors, but also improved the drug accumulation in the macrophages of these two tissues.

“What we found was striking,” Sun said. “If we used this nanoparticle to deliver drugs to modulate the tumor and lymph nodes, we achieved long-term tumor remission and eliminated lung metastases, which we’d never seen before.”

Without Nano-PI, Sun says the drugs worked fine but the results were mediocre. But once they implemented the nanoparticle in this way, the team achieved almost 200 days without the tumor growing back, compared to most mice models where the tumor returns in 90 days.

“It’s not a cure,” Sun quickly added, “but it represents a promising candidate for future clinical trials and gives us indication that maybe we can achieve long-term tumor remission.”

In this study, Sun used different design criteria to develop Nano-PI, which is drug-specific, nanocarrier-specific, target cell-specific, and disease-specific, to deliver drugs into the macrophages of two types of tissues. Specifically, Nano-PI was able to target M2-macrophages, which are one of the major immunosuppressive factors that require regulation to treat metastatic breast cancer. The designs shown in Nano-PI suggest the possibility of enhanced immunotherapy efficacy to achieve long-term complete tumor remission that may have better clinical translation in patients with TNBC.

Sun says that nanomedicine in general has not been very successful in cancer treatment, largely due to poor clinical translation from preclinical models to cancer patients. But in this study, Sun and his team found a possible way to increase the efficacy of this nanotechnology.

“Our findings suggest that maybe the previous nanomedicine design principles themselves are wrong.”

Sun and his team used new design criteria for nanomedicine that was drug-specific, meaning it must be used to overcome a specific problem in a specific setting.

“You cannot have universal nanomedicine to do universal tasks,” Sun said. “It cannot solve all problems for all drugs. The old design principle sees nanomedicine as universal, but that doesn’t succeed when translated from mice models to clinical trials. We’re finding that it must be drug specific, nanocarrier specific, cell type specific. Each nanocarrier will have its own property and can only do certain things to achieve efficacy for patients.

To further test this new philosophy, and to continue to explore the efficacy of targeting lymph nodes and tumors simultaneously, Sun hopes these findings can move toward clinical trial.

“The technology is mature enough that we can manufacture this nanomedicine that would deliver drugs to see if it will translate to human trial and really achieve long-term remission.”



Competing interests: A patent application entitled “PI3K inhibitors, nanoformulations, and uses thereof” (63/176,930) related to this study has been filed. Tudong Song, Luke Bugada, Fei Wen, Wei Gao, Hongxiang Hu, Ruiting Li, and Duxin Sun are inventors of the patent.

Funding: This work was supported, in part, by the internal funding of College of Pharmacy at University of Michigan.

####

For more information, please click here

Contacts:
Anna Megdell
Michigan Medicine - University of Michigan

Copyright © Michigan Medicine - University of Michigan

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Paper cited: “Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice,” Science Translational Medicine. DOI: 10.1126/scitranslmed.abl3649:

Related News Press

News and information

Drawing data in nanometer scale September 30th, 2022

Researchers unveil mystery inside Li- o2 batteries September 30th, 2022

Synthesis of air-stable room-temperature van der Waals magnetic thin flakes September 30th, 2022

ACM Research Launches New Furnace Tool for Thermal Atomic Layer Deposition to Support Advanced Semiconductor Manufacturing Requirements: Ultra Fn A Furnace Tool Shipped to China-Based Foundry Customer September 30th, 2022

Cancer

How different cancer cells respond to drug-delivering nanoparticles: The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer July 22nd, 2022

New technology helps reveal inner workings of human genome June 24th, 2022

New nano-gel to protect children receiving chemotherapy from hearing loss June 17th, 2022

Electron-phonon coupling assisted universal red luminescence of o-phenylenediamine-based CDs June 10th, 2022

Possible Futures

Researchers unveil mystery inside Li- o2 batteries September 30th, 2022

Synthesis of air-stable room-temperature van der Waals magnetic thin flakes September 30th, 2022

Layer Hall effect and hidden Berry curvature in antiferromagnetic insulators September 30th, 2022

ACM Research Launches New Furnace Tool for Thermal Atomic Layer Deposition to Support Advanced Semiconductor Manufacturing Requirements: Ultra Fn A Furnace Tool Shipped to China-Based Foundry Customer September 30th, 2022

Discoveries

Surface microstructures of lunar soil returned by Chang’e-5 mission reveal an intermediate stage in space weathering process September 30th, 2022

Researchers unveil mystery inside Li- o2 batteries September 30th, 2022

Synthesis of air-stable room-temperature van der Waals magnetic thin flakes September 30th, 2022

Layer Hall effect and hidden Berry curvature in antiferromagnetic insulators September 30th, 2022

Announcements

Researchers unveil mystery inside Li- o2 batteries September 30th, 2022

Synthesis of air-stable room-temperature van der Waals magnetic thin flakes September 30th, 2022

Layer Hall effect and hidden Berry curvature in antiferromagnetic insulators September 30th, 2022

ACM Research Launches New Furnace Tool for Thermal Atomic Layer Deposition to Support Advanced Semiconductor Manufacturing Requirements: Ultra Fn A Furnace Tool Shipped to China-Based Foundry Customer September 30th, 2022

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Conformal optical black hole for cavity September 30th, 2022

Cleveland researchers reveal new strategy to prevent blood clots without increasing the risk of bleeding: University Hospitals and Case Western Reserve University findings may be especially impactful for cancer patients who experience blood clot complications September 30th, 2022

Ultrasmall VN/Co heterostructure with optimized N active sites anchored in N-doped graphitic nanocarbons for boosting hydrogen evolution September 30th, 2022

Layer Hall effect and hidden Berry curvature in antiferromagnetic insulators September 30th, 2022

Patents/IP/Tech Transfer/Licensing

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care July 21st, 2020

A new study published on the cover of Science could bolster the development of batteries, fuel cells, 3D printing technologies and more May 1st, 2020

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Drawing data in nanometer scale September 30th, 2022

Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022

Scientists take control of magnetism at the microscopic level: Neutrons reveal remarkable atomic behavior in thermoelectric materials for more efficient conversion of heat into electricity August 26th, 2022

Understanding outsize role of nanopores: New research reveals differences in pH, and more, about these previously mysterious environments August 26th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project